An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability
Deficits in social interaction (SI) are a core symptom of autism spectrum disorders (ASDs); however, treatments for social deficits are notably lacking. Elucidating brain circuits and neuromodulatory signaling systems that regulate sociability could facilitate a deeper understanding of ASD pathophysiology and reveal novel treatments for ASDs. Here we found that in vivo optogenetic activation of the basolateral amygdala-nucleus accumbens (BLA-NAc) glutamatergic circuit reduced SI and increased social avoidance in mice. Furthermore, we found that 2-arachidonoylglycerol (2-AG) endocannabinoid signaling reduced BLA-NAc glutamatergic activity and that pharmacological 2-AG augmentation via administration of JZL184, a monoacylglycerol lipase inhibitor, blocked SI deficits associated with in vivo BLA-NAc stimulation. Additionally, optogenetic inhibition of the BLA-NAc circuit markedly increased SI in the Shank3B-/- mouse, an ASD model with substantial SI impairment, without affecting SI in WT mice. Finally, we demonstrated that JZL184 delivered systemically or directly to the NAc also normalized SI deficits in Shank3B-/- mice, while ex vivo JZL184 application corrected aberrant NAc excitatory and inhibitory neurotransmission and reduced BLA-NAc-elicited feed-forward inhibition of NAc neurons in Shank3B-/- mice. These data reveal circuit-level and neuromodulatory mechanisms regulating social function relevant to ASDs and suggest 2-AG augmentation could reduce social deficits via modulation of excitatory and inhibitory neurotransmission in the NAc.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:130 |
---|---|
Enthalten in: |
The Journal of clinical investigation - 130(2020), 4 vom: 01. Apr., Seite 1728-1742 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Folkes, Oakleigh M [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 30.12.2020 Date Revised 29.03.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1172/JCI131752 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM304742708 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM304742708 | ||
003 | DE-627 | ||
005 | 20231225115633.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1172/JCI131752 |2 doi | |
028 | 5 | 2 | |a pubmed24n1015.xml |
035 | |a (DE-627)NLM304742708 | ||
035 | |a (NLM)31874107 | ||
035 | |a (PII)131752 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Folkes, Oakleigh M |e verfasserin |4 aut | |
245 | 1 | 3 | |a An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.12.2020 | ||
500 | |a Date Revised 29.03.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Deficits in social interaction (SI) are a core symptom of autism spectrum disorders (ASDs); however, treatments for social deficits are notably lacking. Elucidating brain circuits and neuromodulatory signaling systems that regulate sociability could facilitate a deeper understanding of ASD pathophysiology and reveal novel treatments for ASDs. Here we found that in vivo optogenetic activation of the basolateral amygdala-nucleus accumbens (BLA-NAc) glutamatergic circuit reduced SI and increased social avoidance in mice. Furthermore, we found that 2-arachidonoylglycerol (2-AG) endocannabinoid signaling reduced BLA-NAc glutamatergic activity and that pharmacological 2-AG augmentation via administration of JZL184, a monoacylglycerol lipase inhibitor, blocked SI deficits associated with in vivo BLA-NAc stimulation. Additionally, optogenetic inhibition of the BLA-NAc circuit markedly increased SI in the Shank3B-/- mouse, an ASD model with substantial SI impairment, without affecting SI in WT mice. Finally, we demonstrated that JZL184 delivered systemically or directly to the NAc also normalized SI deficits in Shank3B-/- mice, while ex vivo JZL184 application corrected aberrant NAc excitatory and inhibitory neurotransmission and reduced BLA-NAc-elicited feed-forward inhibition of NAc neurons in Shank3B-/- mice. These data reveal circuit-level and neuromodulatory mechanisms regulating social function relevant to ASDs and suggest 2-AG augmentation could reduce social deficits via modulation of excitatory and inhibitory neurotransmission in the NAc | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Neuroscience | |
650 | 4 | |a Psychiatric diseases | |
650 | 7 | |a Endocannabinoids |2 NLM | |
650 | 7 | |a Microfilament Proteins |2 NLM | |
650 | 7 | |a Nerve Tissue Proteins |2 NLM | |
650 | 7 | |a Shank3 protein, mouse |2 NLM | |
700 | 1 | |a Báldi, Rita |e verfasserin |4 aut | |
700 | 1 | |a Kondev, Veronika |e verfasserin |4 aut | |
700 | 1 | |a Marcus, David J |e verfasserin |4 aut | |
700 | 1 | |a Hartley, Nolan D |e verfasserin |4 aut | |
700 | 1 | |a Turner, Brandon D |e verfasserin |4 aut | |
700 | 1 | |a Ayers, Jade K |e verfasserin |4 aut | |
700 | 1 | |a Baechle, Jordan J |e verfasserin |4 aut | |
700 | 1 | |a Misra, Maya P |e verfasserin |4 aut | |
700 | 1 | |a Altemus, Megan |e verfasserin |4 aut | |
700 | 1 | |a Grueter, Carrie A |e verfasserin |4 aut | |
700 | 1 | |a Grueter, Brad A |e verfasserin |4 aut | |
700 | 1 | |a Patel, Sachin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of clinical investigation |d 1924 |g 130(2020), 4 vom: 01. Apr., Seite 1728-1742 |w (DE-627)NLM000005487 |x 1558-8238 |7 nnns |
773 | 1 | 8 | |g volume:130 |g year:2020 |g number:4 |g day:01 |g month:04 |g pages:1728-1742 |
856 | 4 | 0 | |u http://dx.doi.org/10.1172/JCI131752 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 130 |j 2020 |e 4 |b 01 |c 04 |h 1728-1742 |